Clinical Trial Update: Doxorubicin-eluting LC Bead M1 for Patients With Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update showing results for doxorubicin-eluting LC Bead M1 in hepatocellular carcinoma; the study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin-eluting LC Bead M1 (doxorubicin-eluting LC bead M1)

Snippet

Sponsor: Yale University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2017-08-11